Difference between revisions of "ATC code M05"
Physchim62 (talk | contribs) (Imported from http://en.wikipedia.org/w/index.php?title=ATC_code_M05&oldid=302430114) |
Physchim62 (talk | contribs) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | {{ATC M}} | ||
| + | '''ATC code M05''' is a second-level (therapeutic) group in the [[World Health Organization|WHO]] [[Anatomical Therapeutic Chemical classification]]. It corresponds to drugs for the treatment of bone diseases.<ref>{{ATC index | accessdate = 2009-12-05}}.</ref> | ||
| + | |||
==M05B Drugs affecting bone structure and mineralization== | ==M05B Drugs affecting bone structure and mineralization== | ||
| − | ===M05BA | + | ===M05BA Bisphosphonates=== |
:M05BA01 [[Etidronic acid]] | :M05BA01 [[Etidronic acid]] | ||
:M05BA02 [[Clodronic acid]] | :M05BA02 [[Clodronic acid]] | ||
| Line 16: | Line 19: | ||
:M05BB04 Risedronic acid, calcium and colecalciferol, sequential | :M05BB04 Risedronic acid, calcium and colecalciferol, sequential | ||
| − | ===M05BC | + | ===M05BC Bone morphogenetic proteins=== |
:M05BC01 [[Dibotermin alfa]] | :M05BC01 [[Dibotermin alfa]] | ||
:M05BC02 [[Eptotermin alfa]] | :M05BC02 [[Eptotermin alfa]] | ||
| Line 29: | Line 32: | ||
[[Category:ATC codes|M05]] | [[Category:ATC codes|M05]] | ||
| + | [[Category:Drugs for the treatment of bone diseases| ]] | ||
{{Imported from Wikipedia|name=ATC code M05|id=302430114}} | {{Imported from Wikipedia|name=ATC code M05|id=302430114}} | ||
Latest revision as of 07:05, 13 December 2009
| ||||||||||||||||||||
ATC code M05 is a second-level (therapeutic) group in the WHO Anatomical Therapeutic Chemical classification. It corresponds to drugs for the treatment of bone diseases.[1]
Contents
M05B Drugs affecting bone structure and mineralization
M05BA Bisphosphonates
- M05BA01 Etidronic acid
- M05BA02 Clodronic acid
- M05BA03 Pamidronic acid
- M05BA04 Alendronic acid
- M05BA05 Tiludronic acid
- M05BA06 Ibandronic acid
- M05BA07 Risedronic acid
- M05BA08 Zoledronic acid
M05BB Bisphosphonates, combinations
- M05BB01 Etidronic acid and calcium, sequential
- M05BB02 Risedronic acid and calcium, sequential
- M05BB03 Alendronic acid and colecalciferol
- M05BB04 Risedronic acid, calcium and colecalciferol, sequential
M05BC Bone morphogenetic proteins
- M05BC01 Dibotermin alfa
- M05BC02 Eptotermin alfa
M05BX Other drugs affecting bone structure and mineralization
- M05BX01 Ipriflavone
- M05BX02 Aluminium chlorohydrate
- M05BX03 Strontium ranelate
References
- ↑ ATC/DDD Index; WHO Collaborating Centre for Drug Statistics Methodology, <http://www.whocc.no/atcddd/indexdatabase/>. (accessed 5 December 2009).
| Error creating thumbnail: Unable to save thumbnail to destination |  |
This page was originally imported from Wikipedia, specifically this version of the article "ATC code M05". Please see the history page on Wikipedia for the original authors. This WikiChem article may have been modified since it was imported. It is licensed under the Creative Commons Attribution–Share Alike 3.0 Unported license. |
